{"product_id":"igf1-des-1mg-vial","title":"IGF1-Des 2mg vial","description":"\u003cp data-start=\"481\" data-end=\"953\" class=\"\"\u003e\u003cstrong data-start=\"481\" data-end=\"494\"\u003e\u003cstrong data-end=\"392\" data-start=\"377\"\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e                                           \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003cstrong\u003e\u003cspan\u003eF\u003c\/span\u003eOR HUMAN CONSUMPTION\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"481\" data-end=\"953\" class=\"\"\u003e\u003cstrong data-start=\"481\" data-end=\"494\"\u003eIGF-1 DES\u003c\/strong\u003e, also known as \u003cstrong data-start=\"510\" data-end=\"528\"\u003eIGF-1 DES(1-3)\u003c\/strong\u003e, is a truncated variant of the naturally occurring peptide hormone \u003cstrong data-start=\"596\" data-end=\"636\"\u003eInsulin-like Growth Factor 1 (IGF-1)\u003c\/strong\u003e. IGF-1 is a critical growth factor that mediates the effects of growth hormone (GH) in tissues, especially muscle, bone, and cartilage. The DES(1-3) form is characterized by the removal of the first three amino acids at the N-terminal, making IGF-1 DES shorter, more potent, and faster-acting than full-length IGF-1.\u003c\/p\u003e\n\u003chr data-start=\"955\" data-end=\"958\" class=\"\"\u003e\n\u003ch2 data-start=\"960\" data-end=\"997\" class=\"\"\u003eChemical and Biological Properties\u003c\/h2\u003e\n\u003cul data-start=\"999\" data-end=\"1415\"\u003e\n\u003cli data-start=\"999\" data-end=\"1030\" class=\"\"\u003e\n\u003cp data-start=\"1001\" data-end=\"1030\" class=\"\"\u003e\u003cstrong data-start=\"1001\" data-end=\"1015\"\u003eFull Name:\u003c\/strong\u003e IGF-1 DES(1-3)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1031\" data-end=\"1135\" class=\"\"\u003e\n\u003cp data-start=\"1033\" data-end=\"1135\" class=\"\"\u003e\u003cstrong data-start=\"1033\" data-end=\"1047\"\u003eStructure:\u003c\/strong\u003e Shortened variant of IGF-1 with the removal of amino acids 1–3 from the N-terminal end.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1136\" data-end=\"1272\" class=\"\"\u003e\n\u003cp data-start=\"1138\" data-end=\"1272\" class=\"\"\u003e\u003cstrong data-start=\"1138\" data-end=\"1165\"\u003eMolecular Modification:\u003c\/strong\u003e Shorter structure increases potency, affinity for IGF-1 receptors, and resistance to IGF-binding proteins.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1273\" data-end=\"1415\" class=\"\"\u003e\n\u003cp data-start=\"1275\" data-end=\"1415\" class=\"\"\u003e\u003cstrong data-start=\"1275\" data-end=\"1301\"\u003eAdministration Routes:\u003c\/strong\u003e Primarily administered via subcutaneous or intramuscular injection due to peptide bioavailability considerations.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"1417\" data-end=\"1420\" class=\"\"\u003e\n\u003ch2 data-start=\"1422\" data-end=\"1444\" class=\"\"\u003eMechanism of Action\u003c\/h2\u003e\n\u003cp data-start=\"1446\" data-end=\"1575\" class=\"\"\u003eIGF-1 DES exhibits enhanced biological activity and rapid action due to key structural differences compared to full-length IGF-1:\u003c\/p\u003e\n\u003ch3 data-start=\"1577\" data-end=\"1623\" class=\"\"\u003e1. Increased Receptor Affinity and Potency\u003c\/h3\u003e\n\u003cul data-start=\"1624\" data-end=\"1755\"\u003e\n\u003cli data-start=\"1624\" data-end=\"1755\" class=\"\"\u003e\n\u003cp data-start=\"1626\" data-end=\"1755\" class=\"\"\u003eGreater affinity and potency at IGF-1 receptors, significantly amplifying its anabolic, anti-catabolic, and regenerative effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"1757\" data-end=\"1807\" class=\"\"\u003e2. Resistance to IGF-Binding Proteins (IGFBPs)\u003c\/h3\u003e\n\u003cul data-start=\"1808\" data-end=\"1943\"\u003e\n\u003cli data-start=\"1808\" data-end=\"1943\" class=\"\"\u003e\n\u003cp data-start=\"1810\" data-end=\"1943\" class=\"\"\u003eReduced binding affinity to IGFBPs, allowing free circulation and immediate bioactivity, leading to rapid cellular uptake and action.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"1945\" data-end=\"1981\" class=\"\"\u003e3. Anabolic and Myogenic Effects\u003c\/h3\u003e\n\u003cul data-start=\"1982\" data-end=\"2144\"\u003e\n\u003cli data-start=\"1982\" data-end=\"2062\" class=\"\"\u003e\n\u003cp data-start=\"1984\" data-end=\"2062\" class=\"\"\u003ePromotes muscle cell proliferation (hyperplasia), differentiation, and growth.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2063\" data-end=\"2144\" class=\"\"\u003e\n\u003cp data-start=\"2065\" data-end=\"2144\" class=\"\"\u003eEnhances satellite cell activation, critical for muscle repair and hypertrophy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"2146\" data-end=\"2178\" class=\"\"\u003e4. Anti-Catabolic Properties\u003c\/h3\u003e\n\u003cul data-start=\"2179\" data-end=\"2283\"\u003e\n\u003cli data-start=\"2179\" data-end=\"2283\" class=\"\"\u003e\n\u003cp data-start=\"2181\" data-end=\"2283\" class=\"\"\u003eProtects muscle tissue from breakdown, especially in conditions of stress, injury, or caloric deficit.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"2285\" data-end=\"2288\" class=\"\"\u003e\n\u003ch2 data-start=\"2290\" data-end=\"2344\" class=\"\"\u003ePotential Therapeutic and Experimental Applications\u003c\/h2\u003e\n\u003cp data-start=\"2346\" data-end=\"2438\" class=\"\"\u003eIGF-1 DES has demonstrated promising results in preclinical research and experimental usage:\u003c\/p\u003e\n\u003ch3 data-start=\"2440\" data-end=\"2490\" class=\"\"\u003e1. Muscle Hypertrophy and Athletic Performance\u003c\/h3\u003e\n\u003cul data-start=\"2491\" data-end=\"2635\"\u003e\n\u003cli data-start=\"2491\" data-end=\"2635\" class=\"\"\u003e\n\u003cp data-start=\"2493\" data-end=\"2635\" class=\"\"\u003eRapid and pronounced muscle growth, improved recovery, and enhanced muscular strength, popular among bodybuilders and athletes experimentally.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"2637\" data-end=\"2669\" class=\"\"\u003e2. Muscle-Wasting Conditions\u003c\/h3\u003e\n\u003cul data-start=\"2670\" data-end=\"2783\"\u003e\n\u003cli data-start=\"2670\" data-end=\"2783\" class=\"\"\u003e\n\u003cp data-start=\"2672\" data-end=\"2783\" class=\"\"\u003ePotential therapeutic use in treating muscle atrophy related to chronic illness, aging (sarcopenia), or injury.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"2785\" data-end=\"2831\" class=\"\"\u003e3. Injury Rehabilitation and Tissue Repair\u003c\/h3\u003e\n\u003cul data-start=\"2832\" data-end=\"2957\"\u003e\n\u003cli data-start=\"2832\" data-end=\"2957\" class=\"\"\u003e\n\u003cp data-start=\"2834\" data-end=\"2957\" class=\"\"\u003eAccelerates healing of muscle, tendon, ligament injuries, and facilitates rapid rehabilitation following trauma or surgery.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"2959\" data-end=\"2995\" class=\"\"\u003e4. Bone Density and Joint Health\u003c\/h3\u003e\n\u003cul data-start=\"2996\" data-end=\"3118\"\u003e\n\u003cli data-start=\"2996\" data-end=\"3118\" class=\"\"\u003e\n\u003cp data-start=\"2998\" data-end=\"3118\" class=\"\"\u003eImproves bone mineral density and may assist in joint healing, potentially beneficial in osteoporosis or joint injuries.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"3120\" data-end=\"3158\" class=\"\"\u003e5. Metabolic Health (Experimental)\u003c\/h3\u003e\n\u003cul data-start=\"3159\" data-end=\"3298\"\u003e\n\u003cli data-start=\"3159\" data-end=\"3298\" class=\"\"\u003e\n\u003cp data-start=\"3161\" data-end=\"3298\" class=\"\"\u003eMay positively impact insulin sensitivity, lipid metabolism, and overall metabolic function, though less explored than traditional IGF-1.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"3300\" data-end=\"3303\" class=\"\"\u003e\n\u003ch2 data-start=\"3305\" data-end=\"3356\" class=\"\"\u003eDosage and Administration (Experimental Context)\u003c\/h2\u003e\n\u003cp data-start=\"3358\" data-end=\"3549\" class=\"\"\u003eNo standardized clinical dosage guidelines currently exist due to the experimental nature of IGF-1 DES. Typical experimental protocols based on anecdotal reports and limited research include:\u003c\/p\u003e\n\u003cul data-start=\"3551\" data-end=\"3932\"\u003e\n\u003cli data-start=\"3551\" data-end=\"3641\" class=\"\"\u003e\n\u003cp data-start=\"3553\" data-end=\"3641\" class=\"\"\u003e\u003cstrong data-start=\"3553\" data-end=\"3570\"\u003eDosage Range:\u003c\/strong\u003e 20–50 mcg per administration (common experimental dosage: ~25–50 mcg).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3642\" data-end=\"3771\" class=\"\"\u003e\n\u003cp data-start=\"3644\" data-end=\"3771\" class=\"\"\u003e\u003cstrong data-start=\"3644\" data-end=\"3654\"\u003eRoute:\u003c\/strong\u003e Usually intramuscular or subcutaneous injection, immediately before or after exercise to maximize localized effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3772\" data-end=\"3864\" class=\"\"\u003e\n\u003cp data-start=\"3774\" data-end=\"3864\" class=\"\"\u003e\u003cstrong data-start=\"3774\" data-end=\"3788\"\u003eFrequency:\u003c\/strong\u003e Typically dosed 1–2 times per day during training days or recovery periods.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3865\" data-end=\"3932\" class=\"\"\u003e\n\u003cp data-start=\"3867\" data-end=\"3932\" class=\"\"\u003e\u003cstrong data-start=\"3867\" data-end=\"3884\"\u003eCycle Length:\u003c\/strong\u003e Commonly 4–6 weeks of use, followed by a break.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3934\" data-end=\"4044\" class=\"\"\u003e\u003cstrong data-start=\"3934\" data-end=\"3943\"\u003eNote:\u003c\/strong\u003e Above dosages and practices are anecdotal and experimental; rigorous clinical validation is lacking.\u003c\/p\u003e\n\u003chr data-start=\"4046\" data-end=\"4049\" class=\"\"\u003e\n\u003ch2 data-start=\"4051\" data-end=\"4085\" class=\"\"\u003eSafety Profile and Side Effects\u003c\/h2\u003e\n\u003cp data-start=\"4087\" data-end=\"4235\" class=\"\"\u003eWhile IGF-1 DES appears generally well-tolerated in limited experimental contexts, full safety profiles remain unclear due to minimal human studies:\u003c\/p\u003e\n\u003ch3 data-start=\"4237\" data-end=\"4286\" class=\"\"\u003eCommon Side Effects (Mild and Rarely Severe):\u003c\/h3\u003e\n\u003cul data-start=\"4287\" data-end=\"4502\"\u003e\n\u003cli data-start=\"4287\" data-end=\"4343\" class=\"\"\u003e\n\u003cp data-start=\"4289\" data-end=\"4343\" class=\"\"\u003eInjection site redness, irritation, or minor swelling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4344\" data-end=\"4426\" class=\"\"\u003e\n\u003cp data-start=\"4346\" data-end=\"4426\" class=\"\"\u003eMild headaches or temporary hypoglycemia (due to insulin-like properties; rare).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4427\" data-end=\"4502\" class=\"\"\u003e\n\u003cp data-start=\"4429\" data-end=\"4502\" class=\"\"\u003ePossible water retention or transient joint discomfort at higher dosages.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"4504\" data-end=\"4534\" class=\"\"\u003ePotential Long-term Risks:\u003c\/h3\u003e\n\u003cul data-start=\"4535\" data-end=\"4725\"\u003e\n\u003cli data-start=\"4535\" data-end=\"4649\" class=\"\"\u003e\n\u003cp data-start=\"4537\" data-end=\"4649\" class=\"\"\u003eTheoretical concerns include IGF-1-mediated proliferation of existing tumor cells or altered glucose metabolism.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4650\" data-end=\"4725\" class=\"\"\u003e\n\u003cp data-start=\"4652\" data-end=\"4725\" class=\"\"\u003eLong-term human studies and chronic safety data remain limited or absent.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"4727\" data-end=\"4730\" class=\"\"\u003e\n\u003ch2 data-start=\"4732\" data-end=\"4768\" class=\"\"\u003eContraindications and Precautions\u003c\/h2\u003e\n\u003cul data-start=\"4770\" data-end=\"5234\"\u003e\n\u003cli data-start=\"4770\" data-end=\"4947\" class=\"\"\u003e\n\u003cp data-start=\"4772\" data-end=\"4795\" class=\"\"\u003e\u003cstrong data-start=\"4772\" data-end=\"4794\"\u003eContraindications:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"4798\" data-end=\"4947\"\u003e\n\u003cli data-start=\"4798\" data-end=\"4890\" class=\"\"\u003e\n\u003cp data-start=\"4800\" data-end=\"4890\" class=\"\"\u003eActive cancer or pre-existing tumors (due to theoretical risks of promoting tumor growth).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4893\" data-end=\"4947\" class=\"\"\u003e\n\u003cp data-start=\"4895\" data-end=\"4947\" class=\"\"\u003ePregnancy or breastfeeding (unknown safety profile).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4949\" data-end=\"5088\" class=\"\"\u003e\n\u003cp data-start=\"4951\" data-end=\"4974\" class=\"\"\u003e\u003cstrong data-start=\"4951\" data-end=\"4973\"\u003eDrug Interactions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"4977\" data-end=\"5088\"\u003e\n\u003cli data-start=\"4977\" data-end=\"5088\" class=\"\"\u003e\n\u003cp data-start=\"4979\" data-end=\"5088\" class=\"\"\u003ePotential interactions with insulin or oral hypoglycemic medications (due to insulin-like metabolic effects).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5090\" data-end=\"5234\" class=\"\"\u003e\n\u003cp data-start=\"5092\" data-end=\"5109\" class=\"\"\u003e\u003cstrong data-start=\"5092\" data-end=\"5108\"\u003ePrecautions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"5112\" data-end=\"5234\"\u003e\n\u003cli data-start=\"5112\" data-end=\"5234\" class=\"\"\u003e\n\u003cp data-start=\"5114\" data-end=\"5234\" class=\"\"\u003eIndividuals with diabetes or impaired glucose tolerance should consult healthcare professionals before experimental use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"5236\" data-end=\"5239\" class=\"\"\u003e\n\u003ch2 data-start=\"5241\" data-end=\"5271\" class=\"\"\u003eLegal and Regulatory Status\u003c\/h2\u003e\n\u003cul data-start=\"5273\" data-end=\"5599\"\u003e\n\u003cli data-start=\"5273\" data-end=\"5386\" class=\"\"\u003e\n\u003cp data-start=\"5275\" data-end=\"5386\" class=\"\"\u003eIGF-1 DES is \u003cstrong data-start=\"5288\" data-end=\"5304\"\u003enot approved\u003c\/strong\u003e by major regulatory agencies (FDA, EMA, Health Canada) for therapeutic human use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5387\" data-end=\"5466\" class=\"\"\u003e\n\u003cp data-start=\"5389\" data-end=\"5466\" class=\"\"\u003eTypically marketed as a research peptide labeled \"not for human consumption.\"\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5467\" data-end=\"5599\" class=\"\"\u003e\n\u003cp data-start=\"5469\" data-end=\"5599\" class=\"\"\u003eExplicitly banned by WADA (World Anti-Doping Agency) for competitive athletes due to significant performance-enhancing properties.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"5601\" data-end=\"5604\" class=\"\"\u003e\n\u003ch2 data-start=\"5606\" data-end=\"5645\" class=\"\"\u003eCurrent Research Status and Evidence\u003c\/h2\u003e\n\u003cul data-start=\"5647\" data-end=\"6262\"\u003e\n\u003cli data-start=\"5647\" data-end=\"5817\" class=\"\"\u003e\n\u003cp data-start=\"5649\" data-end=\"5675\" class=\"\"\u003e\u003cstrong data-start=\"5649\" data-end=\"5674\"\u003ePreclinical Research:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"5678\" data-end=\"5817\"\u003e\n\u003cli data-start=\"5678\" data-end=\"5817\" class=\"\"\u003e\n\u003cp data-start=\"5680\" data-end=\"5817\" class=\"\"\u003eExtensive animal studies confirm enhanced potency, muscle-building, tissue regeneration, and recovery effects compared to standard IGF-1.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5819\" data-end=\"6074\" class=\"\"\u003e\n\u003cp data-start=\"5821\" data-end=\"5848\" class=\"\"\u003e\u003cstrong data-start=\"5821\" data-end=\"5847\"\u003eHuman Clinical Trials:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"5851\" data-end=\"6074\"\u003e\n\u003cli data-start=\"5851\" data-end=\"5935\" class=\"\"\u003e\n\u003cp data-start=\"5853\" data-end=\"5935\" class=\"\"\u003eExtremely limited; primarily anecdotal evidence from unregulated experimental use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5938\" data-end=\"6074\" class=\"\"\u003e\n\u003cp data-start=\"5940\" data-end=\"6074\" class=\"\"\u003eHuman research focusing explicitly on IGF-1 DES remains sparse, and standardized clinical studies are necessary for robust validation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6076\" data-end=\"6262\" class=\"\"\u003e\n\u003cp data-start=\"6078\" data-end=\"6114\" class=\"\"\u003e\u003cstrong data-start=\"6078\" data-end=\"6113\"\u003eLimitations and Research Needs:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"6117\" data-end=\"6262\"\u003e\n\u003cli data-start=\"6117\" data-end=\"6161\" class=\"\"\u003e\n\u003cp data-start=\"6119\" data-end=\"6161\" class=\"\"\u003eLack of controlled human clinical studies.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6164\" data-end=\"6262\" class=\"\"\u003e\n\u003cp data-start=\"6166\" data-end=\"6262\" class=\"\"\u003eNeed for established optimal dosing, administration protocols, and long-term safety assessments.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"6264\" data-end=\"6267\" class=\"\"\u003e\n\u003ch2 data-start=\"6269\" data-end=\"6311\" class=\"\"\u003eSummary of Potential Benefits and Risks\u003c\/h2\u003e\n\u003cdiv class=\"group pointer-events-none relative flex justify-center *:pointer-events-auto\"\u003e\n\u003cspan class=\"pointer-events-none absolute start-full top-4 z-10 hidden h-full w-fit ps-2 md:block\" data-state=\"closed\"\u003e\u003cbutton class=\"hover:bg-token-main-surface-secondary text-token-text-secondary pointer-events-auto rounded-lg px-1 py-1 opacity-0 transition-opacity duration-200 group-focus-within:opacity-100 group-hover:opacity-100\"\u003e\u003csvg width=\"24\" height=\"24\" viewbox=\"0 0 24 24\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"icon-md-heavy\"\u003e\u003cpath fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M7 5C7 3.34315 8.34315 2 10 2H19C20.6569 2 22 3.34315 22 5V14C22 15.6569 20.6569 17 19 17H17V19C17 20.6569 15.6569 22 14 22H5C3.34315 22 2 20.6569 2 19V10C2 8.34315 3.34315 7 5 7H7V5ZM9 7H14C15.6569 7 17 8.34315 17 10V15H19C19.5523 15 20 14.5523 20 14V5C20 4.44772 19.5523 4 19 4H10C9.44772 4 9 4.44772 9 5V7ZM5 9C4.44772 9 4 9.44772 4 10V19C4 19.5523 4.44772 20 5 20H14C14.5523 20 15 19.5523 15 19V10C15 9.44772 14.5523 9 14 9H5Z\" fill=\"currentColor\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003c\/button\u003e\u003c\/span\u003e\n\u003cdiv class=\"tableContainer horzScrollShadows relative\"\u003e\n\u003ctable class=\"min-w-full\" data-start=\"6313\" data-end=\"6909\"\u003e\n\u003cthead data-start=\"6313\" data-end=\"6411\"\u003e\n\u003ctr data-start=\"6313\" data-end=\"6411\"\u003e\n\u003cth data-start=\"6313\" data-end=\"6356\"\u003e\u003cstrong data-start=\"6315\" data-end=\"6337\"\u003ePotential Benefits\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"6356\" data-end=\"6411\"\u003e\u003cstrong data-start=\"6358\" data-end=\"6393\"\u003ePotential Risks and Limitations\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"6512\" data-end=\"6909\"\u003e\n\u003ctr data-start=\"6512\" data-end=\"6610\"\u003e\n\u003ctd class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)]\" data-start=\"6512\" data-end=\"6555\"\u003eEnhanced muscle growth and regeneration\u003c\/td\u003e\n\u003ctd class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)] min-w-[calc(var(--thread-content-max-width)\/3)]\" data-start=\"6555\" data-end=\"6610\"\u003eLimited human clinical safety and efficacy data\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6611\" data-end=\"6709\"\u003e\n\u003ctd class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)]\" data-start=\"6611\" data-end=\"6654\"\u003eAccelerated injury recovery\u003c\/td\u003e\n\u003ctd class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)] min-w-[calc(var(--thread-content-max-width)\/3)]\" data-start=\"6654\" data-end=\"6709\"\u003ePossible tumor-promoting effects (theoretical risk)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6710\" data-end=\"6810\"\u003e\n\u003ctd class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)]\" data-start=\"6710\" data-end=\"6753\"\u003eImproved bone density and joint health\u003c\/td\u003e\n\u003ctd class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)] min-w-[calc(var(--thread-content-max-width)\/3)]\" data-start=\"6753\" data-end=\"6810\"\u003ePotential metabolic impacts (e.g., glucose regulation)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6811\" data-end=\"6909\"\u003e\n\u003ctd class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)]\" data-start=\"6811\" data-end=\"6854\"\u003eAnti-catabolic and anabolic properties\u003c\/td\u003e\n\u003ctd class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)]\" data-start=\"6854\" data-end=\"6909\"\u003eRegulatory uncertainty and restrictions\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"6911\" data-end=\"6914\" class=\"\"\u003e\n\u003ch2 data-start=\"6916\" data-end=\"6955\" class=\"\"\u003eFuture Directions and Research Needs\u003c\/h2\u003e\n\u003cul data-start=\"6957\" data-end=\"7287\"\u003e\n\u003cli data-start=\"6957\" data-end=\"7050\" class=\"\"\u003e\n\u003cp data-start=\"6959\" data-end=\"7050\" class=\"\"\u003eRigorous human clinical trials to confirm therapeutic efficacy, optimal dosing, and safety.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7051\" data-end=\"7160\" class=\"\"\u003e\n\u003cp data-start=\"7053\" data-end=\"7160\" class=\"\"\u003eLong-term safety studies to address potential risks related to tumor growth, metabolism, and chronic usage.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7161\" data-end=\"7287\" class=\"\"\u003e\n\u003cp data-start=\"7163\" data-end=\"7287\" class=\"\"\u003eExploration of IGF-1 DES’s therapeutic potential in muscle-wasting conditions, injury recovery, and osteoporosis management.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"7289\" data-end=\"7292\" class=\"\"\u003e\n\u003ch2 data-start=\"7294\" data-end=\"7307\" class=\"\"\u003eConclusion\u003c\/h2\u003e\n\u003cp data-start=\"7309\" data-end=\"7807\" class=\"\"\u003eIGF-1 DES is a highly potent, truncated variant of IGF-1 characterized by enhanced bioactivity, resistance to binding proteins, and rapid anabolic and regenerative effects. Although experimental and anecdotal data strongly support its therapeutic promise, significant research gaps, regulatory limitations, and safety concerns remain. Rigorous clinical validation and regulatory approval will be essential before IGF-1 DES can be legitimately recommended for clinical or widespread therapeutic use.\u003c\/p\u003e\n\u003chr data-start=\"7809\" data-end=\"7812\" class=\"\"\u003e\n\u003ch2 data-start=\"7814\" data-end=\"7847\" class=\"\"\u003eReferences \u003c\/h2\u003e\n\u003cul data-start=\"7849\" data-end=\"8334\"\u003e\n\u003cli data-start=\"7849\" data-end=\"7991\" class=\"\"\u003e\n\u003cp data-start=\"7851\" data-end=\"7991\" class=\"\"\u003ePhilippou, A., \u0026amp; Barton, E. R. (2014). \"Optimizing IGF-I for skeletal muscle therapeutics.\" \u003cem data-start=\"7943\" data-end=\"7974\"\u003eGrowth Hormone \u0026amp; IGF Research\u003c\/em\u003e, 24(5), 157–163.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7992\" data-end=\"8217\" class=\"\"\u003e\n\u003cp data-start=\"7994\" data-end=\"8217\" class=\"\"\u003eShavlakadze, T., \u0026amp; Grounds, M. D. (2006). \"Therapeutic interventions for age-related muscle wasting: importance of innervation and exercise for preventing sarcopenia.\" \u003cem data-start=\"8162\" data-end=\"8199\"\u003eJournal of Experimental Gerontology\u003c\/em\u003e, 41(11), 965–981.\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"8341\" data-end=\"8618\" class=\"\"\u003e \u003c\/p\u003e\n\u003cp data-start=\"8341\" data-end=\"8618\" class=\"\"\u003e\u003cstrong data-start=\"8341\" data-end=\"8356\"\u003eDisclaimer:\u003c\/strong\u003e\u003cbr data-start=\"8356\" data-end=\"8359\"\u003eThis review is provided for educational purposes. IGF-1 DES is an experimental research peptide not approved by regulatory authorities for clinical therapeutic use. Always consult healthcare professionals before considering experimental compounds or peptides\u003c\/p\u003e","brand":"Mijn winkel","offers":[{"title":"Default Title","offer_id":52684864520530,"sku":null,"price":90.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/igf_des.png?v=1770834935","url":"https:\/\/sciencepeptideslab.com\/products\/igf1-des-1mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}